MALAT1 and Sepsis: In conclusion, lnc‐MALAT1/miR‐125a axis presents excellent value in differentiating sepsis patients from healthy controls and also exhibits positive association with general disease severity, organ injury, inflammation level, and mortality in sepsis patients, which provides the evidence that lnc‐MALAT1/miR‐125a is of potential value as a combination biomarker in sepsis management.